Radiolytic and cellular reduction of a novel hypoxia-activated cobalt(III) prodrug of a chloromethylbenzindoline DNA minor groove alkylator

Biochemical Pharmacology
G-One AhnWilliam R Wilson

Abstract

Metabolic reduction can be used to activate prodrugs in hypoxic regions of tumours, but reduction by ionising radiation is also theoretically attractive. Previously, we showed that a cobalt(III) complex containing 8-hydroxyquinoline (8-HQ) and cyclen ligands releases 8-HQ efficiently on irradiation in hypoxic solutions [Ahn G-O, Ware DC, Denny WA, Wilson WR. Optimization of the auxiliary ligand shell of cobalt(III)(8-hydroxyquinoline) complexes as model hypoxia-selective radiation-activated prodrugs. Radiat Res 2004;162:315-25]. Here we investigate an analogous Co(III) complex containing the potent DNA minor groove alkylator azachloromethylbenzindoline (azaCBI, 1) to determine whether it releases 1 on radiolytic and/or enzymatic reduction under hypoxia. Monitoring by HPLC, the azaCBI ligand in the Co(III)(cyclen)(azaCBI) complex (2) slowly hydrolysed in aqueous solution, in contrast to the free ligand 1 which readily converted to its reactive cyclopropyl form. Irradiation of 2 (30-50 microM) in hypoxic solutions released 1 with yields of 0.57 micromol/J in formate buffer and 0.13 micromol/J in human plasma. Using bioassay methods, cytotoxic activation by irradiation of 2 at 1 microM in hypoxic plasma was readily detectable at c...Continue Reading

References

Jun 1, 1991·International Journal of Radiation Oncology, Biology, Physics·T P MonsonA Mansouri
May 15, 1994·International Journal of Radiation Oncology, Biology, Physics·W R WilsonD C Ware
Jun 1, 1993·Cancer Metastasis Reviews·S RockwellK A Kennedy
Jun 1, 1993·Cancer Metastasis Reviews·P Workman, I J Stratford
Oct 1, 1996·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·M NordsmarkJ Overgaard
Feb 9, 2000·Toxicology and Applied Pharmacology·A E Lee, W R Wilson
Nov 28, 2000·Expert Opinion on Investigational Drugs·W A Denny, W R Wilson
May 30, 2003·Biochemical Society Transactions·A GutierrezN S Scrutton
Jan 31, 2004·International Journal of Radiation Oncology, Biology, Physics·Yuta ShibamotoSei-Ichi Nishimoto
Jul 16, 2004·Seminars in Radiation Oncology·Peter Vaupel
Oct 29, 2004·Journal of Medicinal Chemistry·Laurie L ParkerIan J Stratford

❮ Previous
Next ❯

Citations

May 25, 2011·Nature Reviews. Cancer·William R Wilson, Michael P Hay
Feb 1, 2011·Antioxidants & Redox Signaling·Ute JungwirthPetra Heffeter
Jul 13, 2013·Chinese Journal of Cancer·Christopher P GuiseKe Ding
Feb 1, 2012·Advanced Drug Delivery Reviews·Nora Graf, Stephen J Lippard
Oct 18, 2011·Journal of Inorganic Biochemistry·Elizabeth Teixeira SouzaMarciela Scarpellini
Apr 2, 2008·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Fengying ZhaiLiansheng Song
May 5, 2007·Clinical Oncology : a Journal of the Royal College of Radiologists·P Wardman
Dec 29, 2012·Current Opinion in Chemical Biology·Marie C HeffernThomas J Meade
May 9, 2014·Experimental Biology and Medicine·Shao-Chieh LinShaw-Jenq Tsai
Oct 28, 2016·Advanced Drug Delivery Reviews·Sergio ReyBradly G Wouters
Jan 29, 2016·Dalton Transactions : an International Journal of Inorganic Chemistry·Claire S Allardyce, Paul J Dyson
Jul 8, 2015·Dalton Transactions : an International Journal of Inorganic Chemistry·Catherine R Munteanu, Kogularamanan Suntharalingam
Aug 1, 2014·Angewandte Chemie·Claudia Karnthaler-BenbakkaChristian R Kowol
Dec 1, 2018·Chemical Society Reviews·Martin R Gill, Katherine A Vallis
Sep 11, 2007·Dalton Transactions : an International Journal of Inorganic Chemistry·Matthew D HallTrevor W Hambley
Nov 16, 2007·Organic & Biomolecular Chemistry·Kazuhito TanabeSei-ichi Nishimoto
Mar 2, 2016·Annals of Biomedical Engineering·Jicheng YuZhen Gu
Dec 7, 2018·Current Medicinal Chemistry·Ana M F Phillips, Armando J L Pombeiro
Aug 23, 2011·Dalton Transactions : an International Journal of Inorganic Chemistry·Palanisamy SathyadeviNallasamy Dharmaraj
Mar 1, 2020·Journal of Biological Inorganic Chemistry : JBIC : a Publication of the Society of Biological Inorganic Chemistry·Hana CrlikovaJana Kasparkova
Jul 6, 2016·Chembiochem : a European Journal of Chemical Biology·Paul B CresseyKogularamanan Suntharalingam
Dec 24, 2018·Chemical Society Reviews·Amit SharmaJong Seung Kim
Feb 23, 2007·Archiv der Pharmazie·Ingo Ott, Ronald Gust
Nov 24, 2020·Inorganic Chemistry·Marlene MathuberChristian R Kowol
May 11, 2013·Organic Letters·Kavita SharmaHarinath Chakrapani
Aug 12, 2009·Journal of Inorganic Biochemistry·Elizabeth Teixeira SouzaMarciela Scarpellini

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Cancer Metabolism

In order for cancer cells to maintain rapid, uncontrolled cell proliferation, they must acquire a source of energy. Cancer cells acquire metabolic energy from their surrounding environment and utilize the host cell nutrients to do so. Here is the latest research on cancer metabolism.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.